. ( doi:10.1210/jcem.87.3.8333 ) 26 Erem C Kandemir N Hacihasanoglu A Ersoz HO Ukinc K Kocak M. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome . Endocrine 2004 25 55 – 60 . ( doi:10
Search Results
Jan Calissendorff and Henrik Falhammar
B C M Hermans, J L Derks, H J M Groen, J A Stigt, R J van Suylen, L M Hillen, E C van den Broek, E J M Speel, and A-M C Dingemans
solitary metastases, 64% of patients have N0 disease and 36% N1 disease. The prolonged survival of patients in this study with a Ki-67 PI ≤40% suggests that Ki-67 PI might be used as a prognostic factor in LCNEC patients with solitary brain metastases. A
Sondra O’Callaghan and Hanford Yau
confirm that MAH portends a poor prognosis ( 8 ). In fact, a bedside prognostic score has been developed and used in studies evaluating hypercalcemia as an independent prognostic factor ( 9 , 15 ). Certainly, newer targeted anti-cancer therapies may
Carole Morin, Keo-Morakort Benedetto, Agathe Deville, Laurent Milot, Aurélie Theillaumas, Valérie Hervieu, Mathieu Pioche, Gilles Poncet, Julien Forestier, Laurent François, Francoise Borson-Chazot, Mustapha Adham, Catherine Lombard-Bohas, and Thomas Walter
’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . Journal of Clinical Oncology 2008 26 3063 – 3072 . ( https://doi.org/10.1200/JCO.2007.15.4377 ) 10.1200/JCO.2007.15.4377 31242670 2 Hallet J Law CHL
Catarina Tavares, Maria João Coelho, Catarina Eloy, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batista, Luciana Bueno Ferreira, Elisabete Rios, Samia Selmi-Ruby, Bruno Cavadas, Luísa Pereira, Manuel Sobrinho Simões, and Paula Soares
Endocrinology 2015 173 525 – 540 . ( https://doi.org/10.1530/EJE-15-0254 ) 10.1530/EJE-15-0254 26338373 40 Jukkola A Bloigu R Ebeling T Salmela P Blanco G. Prognostic factors in differentiated thyroid carcinomas and their
Simon Schimmack, Yongchao Yang, Klaus Felix, Markus Herbst, Yixiong Li, Miriam Schenk, Frank Bergmann, Thilo Hackert, and Oliver Strobel
A Dagohoy C Leary C Mares JE Abdalla EK Fleming JB Vauthey JN Rashid A , et al . One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . Journal of
Xi Zhang, Xiurong Shen, Wan Zhou, Mengyun Xu, Yan Xing, Jianping Weng, Shandong Ye, Suowen Xu, Zhi Zhang, and Wei Wang
Naka KK Papathanassiou K Bechlioulis A Pappas K Tigas S Makriyiannis D Antoniou S Kazakos N Margeli A Papassotiriou I Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular
Ruth Therese Casey, Deborah Saunders, Benjamin George Challis, Deborah Pitfield, Heok Cheow, Ashley Shaw, and Helen Lisa Simpson
. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors . Medicine
Aline Stangherlin Martins, Ann Kristine Jansen, Luiz Oswaldo Carneiro Rodrigues, Camila Maria Matos, Marcio Leandro Ribeiro Souza, Juliana Ferreira de Souza, Maria de Fátima Haueisen Sander Diniz, Sandhi Maria Barreto, Leonardo Mauricio Diniz, Nilton Alves de Rezende, and Vincent Michael Riccardi
.1086/320121 ). 7 Zöller M Rembeck B Akesson HO Angervall L . Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden . Acta Dermato-Venereologica 1995 75
Manjeetkaur Sehemby, Prachi Bansal, Vijaya Sarathi, Ashwini Kolhe, Kanchan Kothari, Swati Jadhav-Ramteke, Anurag R Lila, Tushar Bandgar, and Nalini S Shah
. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary – an analysis of 376 women . Gynecologic Oncology 2007 104 396 – 400 . ( https://doi.org/10.1016/j.ygyno.2006.08.032 ) 18 Bhat RA Lim YK Chia YN Yam KL. Sertoli
